Regeneron Pharmaceuticals, Inc.
(NASDAQ:REGN)|
14.75 -0.71 (-4.59%) 1:34ET Delayed |
|
|
|
- Compare REGN with:
- View: Line | Candlestick
Company Profile
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
United States - Map
Phone: (914) 347-7000
Fax: (914) 347-2113
Website: www.regeneron.com
State of incorporation: New York
CEO: Dr. Leonard S. Schleifer, M.D., Ph.D.
Employees: 682
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Discovery/dev of biotechnology-based compounds
A biopharmaceutical company that discovers, develops and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.
Recent news for REGN
-
Regeneron Announces Presentation at the 20th Annual Piper Jaffray Healthcare Conference
Business Wire - 4 hours ago
-
REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online - Nov 20 at 4:00 ET
-
Bright Spots for Investors Discussed in Wall Street Transcript Biotechnology Report
Wall Street Transcript - Nov 19 at 9:19 ET
-
Regeneron Announces Presentation at the Credit Suisse 2008 Healthcare Conference
Business Wire - Nov 10 at 9:30 ET
-
REGENERON PHARMACEUTICALS INC Financials
EDGAR Online Financials - Nov 08 at 9:04 ET
-
Regeneron a Growth Biotech Play
Zacks.com - Nov 06 at 9:53 ET
-
New Star Analyst Rankings for REGENERON PHARMACE
StarMine - Nov 05 at 9:30 ET
-
REGENERON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 05 at 7:19 ET
-
REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online - Nov 04 at 2:27 ET
-
Regeneron Reports Third Quarter 2008 Financial and Operating Results
Business Wire - Nov 04 at 7:00 ET
Top members owning REGN
-
Top 47%
-31.35%3m:
-30.93%YTD:
-
Top 29%
-17.32%3m:
-21.58%YTD:
-
Top 21%
-11.18%3m:
-11.18%YTD: